# A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Study · id `cardio:ct-nct07227532` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07227532](<https://clinicaltrials.gov/study/NCT07227532>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07227532

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 276 participants.

## Technical summary

Registry record NCT07227532. Allocation not applicable; no masking; primary purpose treatment. Start 2025-10-21 (actual); primary completion 2030-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 276 participants (planned count; ClinicalTrials.gov record NCT07227532, source copy `cardio:ctgov-nct07227532-2026-11-04`, retrieved 2026-11-18)
- Started: 2025-10-21 (actual) (ClinicalTrials.gov record NCT07227532, source copy `cardio:ctgov-nct07227532-2026-11-04`, retrieved 2026-11-18)
- Primary completion: 2030-12-31 (anticipated) (ClinicalTrials.gov record NCT07227532, source copy `cardio:ctgov-nct07227532-2026-11-04`, retrieved 2026-11-18)
- Completion: 2030-12-31 (anticipated) (ClinicalTrials.gov record NCT07227532, source copy `cardio:ctgov-nct07227532-2026-11-04`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07227532, source copy `cardio:ctgov-nct07227532-2026-11-04`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07227532-2026-11-04`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
- Acronym: AdmIREPAS
- Condition: Atrial Fibrillation
- Intervention (Device): Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE Generator
- Lead sponsor: Biosense Webster, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Biosense Webster, Inc. (`cardio:org-biosense-webster-inc`)

## Provenance

Content hash: e3207f64ec16feb7bda4f189e8bdf814d8b95f8aa579f6e918fdb8032574e87c
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
